Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 11, 2026 16:00 ET | Source: MBX Biosciences, Inc.

MBX Biosciences to Provide 2026 Outlook and Business Update at 44th Annual J.P. Morgan Healthcare Conference

One-year follow-up data from Phase 2 trial of once-weekly canvuparatide, a potential best-in-class therapy for hypoparathyroidism, anticipated in Q2 2026; Phase 3 initiation on track for Q3 2026 ...
January 11, 2026 16:00 ET | Source: Castle Biosciences, Inc.

Castle Biosciences Announces Preliminary Unaudited Fourth Quarter and Full–Year 2025 Results

Castle today announced certain unaudited preliminary performance results for the fourth quarter and year ended Dec. 31, 2025.
January 11, 2026 15:00 ET | Source: Molecular Partners

Molecular Partners Highlights Clinical Development Progress and Anticipated Milestones at 44th Annual J.P. Morgan Healthcare Conference

Phase 1/2a study with lead Radio-DARPin MP0712 initiated; first patient dosing expected Q1 2026, initial data anticipated in 2026Full imaging and dosimetry data from MP0712 compassionate care program...
January 11, 2026 15:00 ET | Source: Exagen Inc.

Exagen Inc. Announces Select Preliminary 2025 Financial Results

Exagen Inc. announces select preliminary unaudited financial results for the fourth quarter and full year 2025, in line with prior guidance.
January 11, 2026 13:00 ET | Source: Krystal Biotech, Inc.

Krystal Biotech Provides Business Update at 44th Annual J.P. Morgan Healthcare Conference

Preliminary 4Q 2025 VYJUVEK net revenue of $106 million to $107 million Robust clinical pipeline with multibillion dollar opportunities and strong balance sheet for sustained growth PITTSBURGH,...
January 11, 2026 10:05 ET | Source: Commerce.com, Inc.

Commerce Supports Universal Commerce Protocol, Plans to Offer Buying Directly Across Google’s AI Surfaces

AUSTIN, Texas, Jan. 11, 2026 (GLOBE NEWSWIRE) -- Commerce (Nasdaq: CMRC), an open, intelligent ecosystem of technology solutions and the parent company of leading ecommerce platform BigCommerce and...
January 11, 2026 09:30 ET | Source: RxSight, Inc.

RxSight, Inc. Announces Preliminary Q4 and 2025 Financial Results; New Chief Financial Officer

ALISO VIEJO, Calif., Jan. 11, 2026 (GLOBE NEWSWIRE) -- (Nasdaq: RXST) -- RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients...
January 11, 2026 08:00 ET | Source: Benitec Biopharma Inc.

Benitec Biopharma Provides Positive Long-Term Clinical Study Results for BB-301 Phase 1b/2a Clinical Trial Demonstrating Robust Efficacy and Continued Durability of Response

• Patient 1 of Cohort 1 has now completed the 24-month follow-up timepoint, and at month-24 post-treatment Patient 1 continued to demonstrate the powerful disease-modifying effects of BB-301, with...
January 09, 2026 22:20 ET | Source: Foghorn Therapeutics, Inc.

Foghorn Therapeutics Highlights January Equity Financing, Program Progress and Strategic Objectives for 2026

Recently raised $50 million with BVF Partners, Deerfield Management, founding investor Flagship Pioneering and a leading biotech mutual fund in a transaction that will close January 13th, 2026 Phase...
January 09, 2026 20:00 ET | Source: Nasdaq, Inc.

Walmart Inc. to Join the Nasdaq-100 Index® Beginning January 20th, 2026

NEW YORK, Jan. 09, 2026 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq: NDAQ) today announced that Walmart Inc. (Nasdaq: WMT), will become a component of the Nasdaq-100 Index® (NDX®), the Nasdaq-100 Equal...